Authors
Loading...
Randomized trial uncovers DDX28's role in DNA repair and immune suppression in acute myeloid leukemia, suggesting new therapeutic avenues.
Wang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: